4 studies found for:    18216293 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Condition: Leukemia Lymphocytic Chronic B-Cell
Interventions: Drug: CC-292;   Drug: Rituximab
2 Active, not recruiting PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Leukemia;   Leukemia, Lymphocytyc;   CLL (Chronic Lymphocytic Leukemia);   SLL (Small Lymphocytic Lymphoma)
Intervention: Drug: PCI 32765
3 Unknown  A Phase Ib Study of ISF35 in Combination With Chemotherapy (FCR) in Subjects With Relapsed, Refractory, and/or 17p- CLL
Condition: Chronic Lymphocytic Leukemia
Intervention: Biological: ISF35
4 Completed Efficacy and Safety Study of Bendamustine With or Without Rituximab in Chronic Lymphoproliferative Disorders
Condition: Chronic Lymphocytic Leukaemia
Intervention:

Indicates status has not been verified in more than two years